Cargando…
The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis
Advanced hepatic fibrosis occurs in up to 25% of individuals with C282Y homozygous hemochromatosis. Our aim was to determine whether human leukocyte antigen (HLA)-A3 and B7 alleles act as genetic modifiers of the likelihood of advanced hepatic fibrosis. Between 1972 and 2013, 133 HFE C282Y homozygou...
Autores principales: | Olynyk, John K., Grainger, Richard, Currie, Helen, Ramm, Louise E., Ramm, Grant A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183001/ https://www.ncbi.nlm.nih.gov/pubmed/37179448 http://dx.doi.org/10.1038/s41598-023-35028-4 |
Ejemplares similares
-
Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis
por: Chin, Justin, et al.
Publicado: (2019) -
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis
por: Ong, Sim Yee, et al.
Publicado: (2021) -
HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity
por: Barton, James C., et al.
Publicado: (2022) -
Non-HFE hemochromatosis
por: Santos, Paulo Caleb Júnior de Lima, et al.
Publicado: (2012) -
Diabetes in HFE Hemochromatosis
por: Barton, James C., et al.
Publicado: (2017)